Form D · Other

Heavenly RX Ltd.

Toronto, A6 · CIK 0001773103

Offering snapshot reported Sep 9, 2019 · SEC filing

Reported sold
$1M
Offering amount: $1M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 27, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 9, 2019Initial$1,001,667No comparison1SEC filing
Aug 27, 2019Initial$1,076,730No comparison3SEC filing
Aug 27, 2019Initial$179,352No comparison2SEC filing
Aug 27, 2019Initial$190,675No comparison1SEC filing
Aug 27, 2019Initial$112,425No comparison1SEC filing
Jun 13, 2019Initial$59,360No comparison1SEC filing
Jun 13, 2019Initial$59,360No comparison1SEC filing
Apr 25, 2019Initial$632,205No comparison3SEC filing
Apr 8, 2019Initial$111,780No comparison1SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-348255
Common shares @ CAD$0.40 per share.
Common shares @ CAD$0.40 per share.

Source: Form D, filed Sep 9, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mike Beedles Executive
Brady Cobb Director
Peter Liabotis Executive
Bradley Morris Director, Executive
Paul Norman Director
Jeanine Pirro Director
Bill Wolz Executive

Issuer details

Industry: Other (See others in industry)

Address:
100 King Street West, Suite 5600
Toronto, A6, M5X1CR